United States Food and Drug Administration
"United States Food and Drug Administration" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An agency of the PUBLIC HEALTH SERVICE concerned with the overall planning, promoting, and administering of programs pertaining to maintaining standards of quality of foods, drugs, therapeutic devices, etc.
Descriptor ID |
D014486
|
MeSH Number(s) |
I01.409.418.750.600.650.760 N03.540.348.500.500.600.650.760
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "United States Food and Drug Administration".
Below are MeSH descriptors whose meaning is more specific than "United States Food and Drug Administration".
This graph shows the total number of publications written about "United States Food and Drug Administration" by people in this website by year, and whether "United States Food and Drug Administration" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 1 | 1 | 2 |
1997 | 1 | 3 | 4 |
1999 | 0 | 1 | 1 |
2000 | 0 | 1 | 1 |
2001 | 0 | 6 | 6 |
2002 | 0 | 1 | 1 |
2003 | 1 | 4 | 5 |
2004 | 0 | 5 | 5 |
2005 | 2 | 3 | 5 |
2006 | 0 | 9 | 9 |
2007 | 1 | 8 | 9 |
2008 | 1 | 8 | 9 |
2009 | 1 | 9 | 10 |
2010 | 3 | 17 | 20 |
2011 | 0 | 5 | 5 |
2012 | 0 | 11 | 11 |
2013 | 3 | 12 | 15 |
2014 | 1 | 9 | 10 |
2015 | 2 | 14 | 16 |
2016 | 4 | 11 | 15 |
2017 | 1 | 9 | 10 |
2018 | 0 | 13 | 13 |
2019 | 1 | 15 | 16 |
2020 | 2 | 13 | 15 |
2021 | 2 | 10 | 12 |
2022 | 0 | 9 | 9 |
2023 | 0 | 4 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "United States Food and Drug Administration" by people in Profiles.
-
Project Confirm: Accelerated Drug Approvals for Chronic Myeloid Leukemia. Clin Cancer Res. 2023 06 13; 29(12):2179-2183.
-
Overall survival after PARP maintenance treatment in platinum-sensitive relapsed ovarian cancer: opposing views of the US Food and Drug Administration and European Medicines Agency. Int J Gynecol Cancer. 2023 06 05; 33(6):1008-1009.
-
Assessment, Complications, and Surveillance of Breast Implants: Making Sense of 2022 FDA Breast Implant Guidance. J Breast Imaging. 2023 May 22; 5(3):360-372.
-
Viewpoint: What Is Reasonable and Necessary for People Living with AD after the FDA Approves a Treatment? J Prev Alzheimers Dis. 2023; 10(3):344-345.
-
Paediatric Strategy Forum for medicinal product development in mitogen-activated protein kinase pathway inhibitors: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration. Eur J Cancer. 2022 Dec; 177:120-142.
-
Accelerated approvals hit the target in precision oncology. Nat Med. 2022 10; 28(10):1976-1979.
-
Breast Implant-Related Adverse Events During Mammography: An Assessment of the Food and Drug Administration Manufacturer and User Facility Device Experience Database. Ann Plast Surg. 2022 09 01; 89(3):261-266.
-
Gene-based therapeutics for rare genetic neurodevelopmental psychiatric disorders. Mol Ther. 2022 07 06; 30(7):2416-2428.
-
Do You Know How to Assess Risks Posed by Over-the-Counter Vitamin A Supplements? AMA J Ethics. 2022 05 01; 24(5):E376-381.
-
Prospective Pilot Study of Robotic-Assisted Harvest of the Latissimus Dorsi Muscle: A 510(k) Approval Study with U.S. Food and Drug Administration Investigational Device Exemption. Plast Reconstr Surg. 2022 06 01; 149(6):1287-1295.